Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CE U P D A T E ANTIBIOTIC RESISTANCE I David A. Watson, PhD Debby Bogaert What Is Behind Antibiotic Resistance? What then, accounts for the seemingly rapid ABSTRACT Antibiotic resistance develops among bacterialincrease in antibiotic resistance during the past few years? In this series, we will attempt to answer species just as Darwin might have predicted—that is, this through natural selection. Because bacterial species can share question, however speculatively, using the gram-positive cocci Streptococcus pneumoniae and DNA by a variety of mechanisms, and because some of these enterococcal species as examples. microbes are inherently resistant to one or more major antibiotics, we should not be surprised that clinically How and Why Bacteria Resist To understand why antibiotic resistance is important species of bacteria can become resistant to increasing among pathogenic bacteria, one must commonly used antibiotics by chance alone. The rapid understand the background of the microbes increase in the percentage of strains resistant to one or more themselves. antibiotics, especially broad-spectrum agents, may be the result of increased use of such compounds. Evolution of Bacteria and the Role of Mutation This is the first article in a two-part continuing education series on antibiotic resistance. After completion of the series, the reader will be able to explain, at the level of the genetic material itself, basic mechanisms by which bacteria become resistant to the actions of antimicrobial compounds. The reader also will be able to enumerate reasons for the rapid increase in resistance of clinically important bacteria to commonly used antibiotics and articulate a strategy for maintaining the effectiveness of currently available broad-spectrum antimicrobials. From the Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Tex (Dr Watson) and Eijkman-Winkler Institute for Medical and Clinical Microbiology, Utrecht University, Utrecht, The Netherlands (Ms Bogaert). Reprint requests to Dr Watson, 301 University Blvd, Galveston, TX 775551019; and e-mail: david.watson@ utmb.edu 324 More than 50 years ago, British researchers coaxed from the common mold Penicillium a compound that later would prove to be, quite literally, a miracle drug. This monumental achievement changed medicine forever. As recently as the 1960s, it was believed that the availability of a wide variety of antibiotics would end the threat to public health from infectious diseases.1 Following the development of penicillin, other antibacterial compounds were identified and produced in quantity, first from natural sources, later by chemical synthesis. In many cases, researchers were able to induce resistance to the actions of these miracle drugs, even penicillin itself.2 Even so, many of these drugs were widely used for treating bacterial infections, and treatment failures were rare. LABORATORY MEDICINE VOLUME 28, NUMBER 5 MAY 1997 Living organisms evolve when changing environmental conditions prompt the selection of genetic variants within a species over time. Charles Darwin termed this process natural selection. In natural selection, an organism does not specifically target its response to a given selection event (any obstacle to survival) in order to increase the likelihood of its survival; rather, changes occur randomly within the organism's genome. This change may or may not confer increased fitness on the microbe. These alterations are collectively known as mutations. They generally occur at a fixed rate of 1 in 109 to 1 in 1010 replicated base pairs. Mutations can be of the following two basic types, which are further described in Fig 1. 1. One nucleotide may be substituted for another in the organism's DNA. (This process is known as a base substitution or point mutation.) This substitution results in either early termination of protein translation (known as a nonsense mutation), or a change in the amino acid specified by a given codon (a missense mutation). 2. Frameshift mutations may occur, resulting in either the insertion or deletion of a nucleotide. This alteration leads to a shift to the left or to the right in the reading frame used by the ribosome for protein translation from messenger RNA. messenger RNA, on the protein's amino acid sequence resulting from translation. Top, the effect of changes in a single DNA base. Bottom, the effect of frameshift mutations. Yellow indicates codons specifying methionine (always the first amino acid in a growing protein); gray, termination or stop codons; arrows, nucleotide (DNA base) changes, additions, and (The messenger RNA itself is transcribed from the coding strand of DNA, hence the paradigm, DNA ^ RNA * protein.) Mutations in the first or second position of a triplet, or codon, of the DNA bases that encode a growing protein's amino acid are more likely to result in a change in that amino acid than are such changes at the third position of the codon; this phenomenon is known as wobble. If a mutation results in the addition of a different amino acid to a growing protein, then the question becomes whether this altered protein confers greater survivability on the organism in the event of environmental changes. Compared with higher organisms, certain factors are important in the evolution of microbes: • Small genome. Genomes of bacterial species are much smaller than the more complex DNA assemblages of higher plants and animals. Genome size of most pathogenic bacteria is between 1 million and 10 million nucleotide bases, or three orders of magnitude (1,000-fold) less than that of higher organisms. Replication of the entire genome for bacteria requires much less time because far fewer nucleotide bases must be added to make an entirely new copy of a bacterium's DNA. • Short doubling time. Bacteria generally are much smaller than the cells of higher organisms. They therefore require less time to undergo binary fission. If a random mutation occurring within the DNA of a given microbe or acquisition of exogenous DNA from another bacterium confers increased fitness relative to a particular selective pressure, the mutant organism can expand quickly into a previously unfilled niche. Given these two factors, proliferation in an uncolonized niche can be rapid compared with that of higher organisms. (A bacterium with a doubling time of 30 minutes can undergo a sufficient number of divisions to equal the entire human population of the earth in approximately 16 hours given optimal growth conditions.) This occurs through rapid proliferation of a clonal line descended from a single mutated, or otherwise altered, progenitor bacterial cell. This is precisely the case with bacteria that become resistant to antibiotics, as will be discussed in the second article of this series. deletions. The amino acid encoded by each codon is indicated by its threeletter abbreviation in the lower right corner of each box. Arg indicates arginine; Cys, cysteine; Gin, glutamine; His, histidine; Leu, leucine; Met, methionine; Pro, proline. S 0 'E 3 £ E o 0 o Other Ways Bacteria Stay "Fit" Mutation represents only one of a number of ways in which bacterial strains may acquire new and potentially fitness-increasing traits. Entirely new genes can be incorporated from other bacteria through a number of processes, as depicted in Fig 2. These include: • Transformation, during which naked DNA from the ambient environment binds specifically to a receptor on the surface of the bacterium; the DNA is internalized and incorporated into the recipient genome via a process called homologous recombination. MAY 1997 VOLUME 28, NUMBER 5 in C 0 Test Your Knowledge Look for the CE Update exam on Antibiotic Resistance (707) in the June issue of Laboratory Medicine. Participants will earn 2 CMLE credit hours. LABORATORY MEDICINE 325 1. Transformation Fig 2. Three routes by which a bacterial pathogen acquires DNA from another bacterium. Green indicates exogenous transforming DNA; blue, the surface protein specifically involved in binding and internalizing the DNA. Genetic material incorporated into the recipient genome following transformation is represented by a green rectangle superimposed onto the dark blue oval representing the genomic DNA of the recipient. Similarly, DNA incorporated following conjugation or transduction is represented by red and yellow rectangles, respectively. 326 • Conjugation, which is the direct transfer of one or more genes from a donor to a recipient, either by way of a specialized "conjugation" tube or through direct cell-to-cell contact • Transduction, whereby a bacteriophage (a virus capable of infecting a bacterium) incorporates fragments of bacterial DNA into its own genome, which then are transferred to new, previously uninfected, bacterial strains by newly synthesized infectious bacteriophage particles in office visits for both (predominantly bacterial) otitis media in children and sinusitis in adults.3 These two observations, when considered together with the well-described increasing rates of antibiotic resistance by a variety of clinically important bacterial species, led the authors of the study to state that: "Given sufficient time and appropriate circumstances, there is a strong association between the magnitude of use and the emergence and spread of antimicrobial-resistant strains." Even so, data directly bearing on the question of whether increased use of antimicrobials is responsible in whole or in part for increased rates of resistance are lacking. Indirect evidence supporting a link between increasing antibiotic usage and increasing rates of resistance, however, can be found in a recent Spanish study demonstrating a correlation between greater use of ampicillin in a hospital setting and higher levels of resistance to this antibiotic among isolates from their hospital of the major bacterial pathogens of childhood infections4 (Fig 3). In the case of the pneumococcus, among the most statistically significant factors for acquisition of a penicillinresistant strain of this bacterial species is previous or current 3-lactam antibiotic therapy.5-7 It also has been suggested that empiric therapy using vancomycin for infections suspected to be due to methicillin-resistant staphylococcal species may be a major factor in the spread of strains resistant to this antibiotic.8 Each of these mechanisms has been shown to operate in the movement of clinically relevant DNA (antibiotic resistance genes and virulence genes) from one bacterium to another. For example, it is widely acknowledged that the pneumococci have acquired genes encoding altered penicillin-binding proteins via natural Nonantimicrobial Use of Antibiotics transformation. Under laboratory conditions, Another mechanism thought to contribute to Enterococcus faecalis has been shown to transfer antibiotic resistance has been the use of such genes required for expression of the vancomycin- compounds to stimulate growth in agriculturally resistance phenotype to Staphylococcus aureus by important livestock species. Although this comway of DNase-resistant conjugation. Last, the gene- pound is not used in livestock species as a growth encoding pyrogenic exotoxin A in Streptococcus promoter, another antibiotic (bacitracin) pyogenes (group A Streptococcus) is thought to be employed in this fashion leads to overgrowth of transmitted among isolates of this pathogen by Enterococcus faecium in the gut. Livestock species transduction. therefore may serve as an environmental reservoir for vancomycin-resistant E faecium. The use of antibiotics in livestock feed also has been Empiric Antibiotic Usage A recently published comprehensive survey of the linked with the development of antibiotic resis9 prescribing practices of office-based physicians in tance in Salmonella. An example of this is the the United States indicates that use of third- identification of vancomycin resistance among generation cephalosporin antibiotics (a category porcine isolates of enterococcal species followed of antibiotic exhibiting broad-spectrum antimi- by the isolation of genetically identical strains 10 crobial activity) has increased dramatically from humans. within the past 15 years. 3 This increase has occurred concomitantly with a notable increase LABORATORY MEDICINE VOLUME 28, NUMBER 5 MAY 1997 80 1 800 • 400 Conclusion Clinical antibiotic usage presents a man-made selective pressure to bacterial pathogens. Microbes respond to this challenge by evolving toward resistance to antimicrobial compounds in accordance with the principles of natural selection by way of mutation or through acquisition of resistance from other bacteria. In recent years, increasing use of empiric therapy and nonantimicrobial administration of antibiotics have contributed to enhancing this selection pressure.© ~ 60 E S £ 200 = • 100 i 40 • 20 1983 References 1. Burnet M. Natural History of Infectious Disease. Oxford, United Kingdom: Cambridge University Press; 1962:2. 2. Schmidt LH, Sesler CL. Development of resistance to penicillin by pneumococci. Proc Soc Exp Biol Med. 1943; 52:352-357. 3. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-219. 4. Gomez J, Ruiz-Gomez J, Hernandez-Cardona JL, Nunez ML, Cameras M, Valdes M. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis: A prospective study in Murcia, Spain, 1983-1992. Chemotherapy. 1994;40:299-303. 5. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis. 1994;19:884-890. 6. Bedos J-P, Chevret S, Chastang C, Geslin P, Regnier B, and the French Pneumococcus Study Group. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French study. Clin Infect Dis. 1996;22:63-72. 300 < 1986 1989 1992 Year 7. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl JMed. 1995;333:481-486. 8. Centers for Disease Control. Recommendations for preventing the spread of vancomycin resistance: recommendations of the hospital infection control practices advisory committee. MMWR. 1995;44:1-13. 9. Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiologic perspective. Science. 1986; 234:964-969. 10. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 1994;34:507-514. Glossary Amino acid—one of a group of 20 related compounds that are the component subunits of proteins (3-lactam antibiotic—one of a group of antibiotics possessing a (3-lactam ring as part of the primary structure of the molecule Binary fission—division into two equal daughter cells Codon—group of three nucleotide bases specifying the proper amino acid to add to a growing protein molecule Conjugation—direct passage of DNA from one bacterial cell to another with which it is in contact DNase-resistant conjugation—movement of DNA between cells in a fashion that is resistant to D N A - d e g r a d i n g enzymes (DNases) Empiric antibiotic therapy—initiated on the basis of signs and symptoms, but when definitive identification by bacterial culture or other accepted diagnostic methodology is lacking Evolution—a process resulting in genetic changes that can be passed on to successive generations in a population Fitness—a relative measure of the ability of an organism to survive under a given set of selective constraints Fig 3. Results of a prospective study conducted in a Spanish hospital. Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to ampicillin were followed over time relative to overall hospital usage of this same antibiotic. As usage of ampicillin increased, resistance to this antibiotic increased. Frameshift mutation—addition or removal of one or a few nucleotide bases resulting in a shift to the left or right in the reading frame for a given protein Genome—the DNA comprising all of the genetic information for a given species Mutations—changes in the composition of c o m p o n e n t bases encoding genes within the genome of a given organism Reading frame—the proper placement of nucleotide bases into groups of three to allow for the transcription and translation of a gene product Substitution mutation—exchange of one nucleotide base for another at a specific position within the genome of a given organism Transcription—the synthesis of a messenger RNA molecule encoding a protein by an RNA polymerase using DNA as the template Transduction—transfer of a gene from one bacterium to another by way of a bacteriophage (a virus that infects a bacterium) Transformation—uptake and expression of exogenous DNA by a bacterium Translation—synthesis of a protein by a ribosome from a messenger RNA molecule used as a template MAY 1997 VOLUME 28, NUMBER 5 LABORATORY MEDICINE 327